GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » Debt-to-EBITDA

DocMorris AG (XSWX:DOCM) Debt-to-EBITDA : -4.79 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocMorris AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF94.5 Mil. DocMorris AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF236.3 Mil. DocMorris AG's annualized EBITDA for the quarter that ended in Dec. 2023 was CHF-69.1 Mil. DocMorris AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -4.79.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for DocMorris AG's Debt-to-EBITDA or its related term are showing as below:

XSWX:DOCM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -57.87   Med: -5.31   Max: 4.53
Current: -5.9

During the past 13 years, the highest Debt-to-EBITDA Ratio of DocMorris AG was 4.53. The lowest was -57.87. And the median was -5.31.

XSWX:DOCM's Debt-to-EBITDA is ranked worse than
100% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs XSWX:DOCM: -5.90

DocMorris AG Debt-to-EBITDA Historical Data

The historical data trend for DocMorris AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocMorris AG Debt-to-EBITDA Chart

DocMorris AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -27.44 -6.65 -3.30 -4.72 -5.90

DocMorris AG Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.30 -5.60 -4.05 -9.39 -4.79

Competitive Comparison of DocMorris AG's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, DocMorris AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocMorris AG's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DocMorris AG's Debt-to-EBITDA falls into.



DocMorris AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocMorris AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(94.543 + 236.272) / -56.082
=-5.90

DocMorris AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(94.543 + 236.272) / -69.072
=-4.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


DocMorris AG  (XSWX:DOCM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


DocMorris AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of DocMorris AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


DocMorris AG (XSWX:DOCM) Business Description

Traded in Other Exchanges
Address
Walzmuhlestrasse 60, Frauenfeld, CHE, 8500
DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines